|
- No Greater Amputation Risk with Canagliflozin in T2D Patients MedPage Today
- OBSERVE-4D: No amputation risk with canagliflozin in type 2 diabetes Healio
- Real World Study Suggests Canagliflozin Does Not Increase Risk of Below-Knee Amputation in People with Type 2 ... Idaho State JournalFull coverage
|
0 comments:
Post a Comment